Recent Posts

1. 

   Sotyktu floundering

   34 million in revenue in the US! Notice that is not profit. There is positively no way that we can sustain this sales force with overlays on top. They are going to have to trim the fat. Please notice that the investor asked a very point blank...

   Bristol-Myers Squibb

   anonymous

   Apr 25, 2024 at 9:13 AM

2. 

   Nurtec Performance--Why so bad?

   KM can’t do his pharmacy scams anymore

   Pfizer

   anonymous

   Apr 25, 2024 at 9:10 AM

3. 

   Layoffs coming?

   DEI Didn’t Earn It

   Sanofi

   anonymous

   Apr 25, 2024 at 9:09 AM

4. 

   Tough times

   Plus $1.5B in savings by the end of 2025. More cuts needed to get to that number.

   Bristol-Myers Squibb

   anonymous

   Apr 25, 2024 at 8:56 AM

5. 

   Noncompete Relief

   They can't and won't do anything. They may bark and growl, but they have no bite. The days of these sorts of non-competes being enforceable, even in states like Florida, are over. This is just another example of pure arrogance and outdated,...

   Arthrex

   anonymous

   Apr 25, 2024 at 8:33 AM

6. 

   Cobalt is Max 8

   This is one of the biggest untold stories in med tech. FDA kmows it but is letting docs decide but no one is telling them. Some risk mananagement leaders at hospitsls hsve pickrd it up.

   Medtronic

   anonymous

   Apr 25, 2024 at 8:27 AM

7. 

   Suzanna ABL

   Definitely agree. My guess is FL RD will be gone or reassigned before the end of 2024.

   Novartis

   anonymous

   Apr 25, 2024 at 8:27 AM

8. + Show More